SWOT Analysis
- S
- W
- O
- T
Technical Analysis
Moving Averages
We appreciate your patience. Your content is on the way.
Current Price
- Bullish Moving Averages
- Bearish Moving Averages
Resistance and support
We appreciate your patience. Your content is on the way.
Company Financials
- Profit and loss statement
- Balance sheet
- Quarterly Result
- Ratio
We appreciate your patience. Your content is on the way.
Quick Results Snapshot
We appreciate your patience. Your content is on the way.
Stocks Comparison
Table
Chart
We appreciate your patience. Your content is on the way.
Corporate Action
- Announcement
- Board Meeting
- Dividend
- Split
- Rights
- Events
Insider & Institutional Activity
- Bulk Block Deals
- Insider Trading & SAST
We appreciate your patience. Your content is on the way.
About Centenial Surgical Suture Ltd
Stock PE (TTM)
Promoter Holding
Book Value
ROCE
ROE
Incorporated in 1995, Centenial Surgical Suture Limited is engaged in the manufacture and sale of surgical sutures in India. The company offers absorbable sutures that include natural and synthetic sutures and non absorbable sutures comprising needles for cardiovascular surgery, monofilament polyamide atraumatic needle suture combinations, monofilament stainless steel, and temporary pacemaker electrodes. It also provides female urinary incontinency sets, titanium haemostatic clips for cardiovascular surgery, non absorbable. Company leverages the expertise and application knowledge of the global suture requirements for cardiovascular sutures in particular, to bring advanced atraumatic needle product development to the Indian Surgeons. Continuous innovation in the areas of design, research and development of atraumatic needle, simulation and validation, testing and services, are the key value creation driver for the Company. Within the cardiovascular division, Centenial offers a wide range of product codes which includes over 300 codes produced catalogue that cover applications for CABG. Company enjoys deep manufacturing capabilities and know-how in Cardiovascular Sutures, materials and atraumatic needles, that makes it a trusted partner. Centenial competes with many domestic and foreign medical device companies ranging from small start-up enterprises that might sell only a single or limited number of competitive products or compete only in a specific market segment, to companies that are larger and more established than, have a broad range of competitive products, participate in numerous markets, tenders and have access to significantly greater financial and marketing resources than Centenial . In addition, the medical device industry is characterized by extensive product research and development and rapid technological advances.
Centenial Surgical Suture share price as on 12 Apr 2026 is Rs. 91.27. Over the past 6 months, the Centenial Surgical Suture share price has decreased by 15.49% and in the last one year, it has decreased by 16.99%. The 52-week low for Centenial Surgical Suture share price was Rs. 76.27 and 52-week high was Rs. 189.
531380
INE405H01018
Jul
Centenial Surgical Suture Ltd FAQs
You can buy Centenial Surgical Suture Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Centenial Surgical Suture Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Apr 10, 2026 04:01 PM the closing price of Centenial Surgical Suture Ltd was Rs.91.27.
The latest PE ratio of Centenial Surgical Suture Ltd as of Apr 10, 2026 04:01 PM is -30.63
The latest PB ratio of Centenial Surgical Suture Ltd as of Apr 10, 2026 04:01 PM is 1.15
The 52-week high of Centenial Surgical Suture Ltd share price is Rs. 189.00 while the 52-week low is Rs. 76.27
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Apr 10, 2026 04:01 PM, the market cap of Centenial Surgical Suture Ltd stood at Rs. 33.30 Cr.
Market Outlook
View allWe appreciate your patience. Your content is on the way.